Plasminogen Activator Inhibitor Type 2 Inhibits Tumor Necrosis Factor α-induced Apoptosis
Open Access
- 1 November 1995
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 270 (46) , 27894-27904
- https://doi.org/10.1074/jbc.270.46.27894
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Processing of complex between urokinase and its type‐2 inhibitor on the cell surfaceFEBS Letters, 1993
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992
- Tumor necrosis factor Characterization at the molecular, cellular and in vivo levelFEBS Letters, 1991
- Programmed cell death: Apoptosis and oncogenesisCell, 1991
- Plasminogen activator inhibitor type‐2 Is a major protein induced in human fibroblasts and SK‐MEL‐109 melanoma cells by tumor necrosis factorJournal of Cellular Physiology, 1990
- Vaccinia Virus Encodes a Family of Genes with Homology to Serine Proteinase InhibitorsJournal of General Virology, 1989
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989
- Determination of intermediates, products and cleavage site in the reaction between plasminogen activator inhibitor type‐2 and urokinasesFEBS Letters, 1988
- Amiloride selectively inhibits the urokinase‐type plasminogen activatorFEBS Letters, 1987
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980